This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Screening, prevention and Early detection (SPED) Research Sub Specialty Lead - West of England

Vacancy details

Closing date: 10 February 2023

We are looking for a SPED subspecialty lead (SSL) who has experience of developing/delivering research in any of the following areas; reducing national cancer mortality through prevention and earlier treatment, advancing the implementation of personalised modern therapies, and of linking clinical services with academic and industry innovation in modern technologies.

The SPED role is a new strategic post which is likely to span several specialities / and subspecialty areas although  is likely to primarily sit with the cancer portfolio.

The SPED Group will lead on the promotion and delivery of research involving cancer SPED, including studies of large-scale molecular screening (genomic, proteomic and other technologies) and studies of SPED for cancer alongside non-cancer conditions.

Key Relationships:

  • SPED National Speciality lead (Dr Richard Lee)
  • LCRN Cancer Speciality  Research Leads (Dr Helen Winter, Ms Claire Newton)
  • LCRN Assistant/Research Delivery Managers (A/RDM) (Dr Claire Matthews)
  • LCRN Clinical Director (Dr Kyla Thomas)
  • LCRN Study Support Service and other cross-cutting functions including Communications, Workforce Development, Patient and Public Involvement & Engagement and Business Intelligence.
  • NIHR Clinical Research Network Coordinating Centre (CRNCC) and subspecialty leads from other LCRNs 

Background

National NIHR and Clinical Research Network:

The National Institute for Health Research (NIHR) is the nation’s largest funder of health and care research.  The NIHR:

  • Funds, supports and delivers high quality research that benefits the NHS, public health and social care
  • Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research
  • Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future
  • Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services
  • Partners with other public funders, charities and industry to maximise the value of research to patients and the economy  

The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. The NIHR Clinical Research Network is led by a national Coordinating Centre and operates through 15 Local Clinical Research Networks (LCRNs) each supporting a national research portfolio for 30 clinical specialty areas.  These local research networks deliver performance across the locality and champion the role of research in healthcare at every level.  At a national level the leadership of each of the 30 specialties is provided by a NIHR CRN Coordinating Centre through five Specialty Cluster offices.

Role Information

Sub-Specialty Information:

Oversight of the delivery of the national cancer research portfolio is managed through the Research Delivery Directorate and is broken down into 13 areas overseen by an SSL in support of the Research Speciality Leads; Lung, Breast, Colorectal, Upper GI, Urology, Gynae, Head and Neck, Brain, Palliative Care, Children and young people, Radiotherapy, Sarcoma and Skin.

The SPED role is a new strategic post which is likely to span several specialities / and subspecialty areas although  is likely to primarily sit with the cancer portfolio.

At a local level the LCRN has Cancer Research Specialty Leadership supported by an ARDM. The principal aim of the local Research Sub-Specialty Lead (SSL) is to ensure that Clinical Research Network West of England (CRN WE) have an active and successful portfolio of research within specific sub-specialty area that meet the priorities and needs of the local population and contribute to the national research agenda. This includes ensuring a balanced portfolio of research studies suited to patients with different disease subtypes, presenting at different locations across the region.  

As part of the development of the SPED area the NIHR are looking to form a group of subspecialty leads to meet in a similar way to the existing national specialty, and disease subspecialty groups. This does, however, differ somewhat as SPED is likely to span multiple clinical specialties and stakeholders, including cancer, gastroenterology, respiratory and many others.

The SPED Group will lead on the promotion and delivery of research involving cancer screening, prevention & early detection (SPED), including studies of large-scale molecular screening (genomic, proteomic and other technologies) and studies of SPED for cancer alongside non-cancer conditions. 

We are looking for an SSL who has experience of developing/delivering research in any of the following areas; reducing national cancer mortality through prevention and earlier treatment, advancing the implementation of personalised modern therapies, and for linking clinical services with academic and industry innovation in modern technologies.

The  SPED SSLs will share these aims and expectations:

The principal aim of the SSL role is to ensure that Local Clinical Research Networks (LCRNs) have an active and successful portfolio of research within specific subspecialty areas that meet the priorities and needs of the local population and contribute to the national research agenda. 

In summary, the essential expectations are to:

  • Review the relevant subspecialty portfolio with the LCRN A/RDMs on a regular basis to identify opportunities for opening studies in the LCRN.
  • Attend up to 3 national subspecialty meetings each year organised by the NIHR CRN Specialty Cluster Office (meetings will be virtual initially).
  • Attend any local meetings as required.
  • Engage with local specialty trainee collaborative if applicable.
  • Engage with the LCRN’s Leadership team and keep the LCRN’s Cancer Specialty Lead abreast of developments.
  • Respond to the CRN’s Early Feedback/Expert Review requests in a timely manner
  • Proactively promote local clinical and other health research active engagement and awareness of research within the specialty

This is an unfunded role, but it is expected that the input required will not exceed 0.5PA

We will jointly review the role on a 12 monthly basis allowing for extension by mutual agreement.

In order to apply please send your CV and a cover letter explaining why you would be a good match for the role to westengland@nihr.ac.uk.